Innovate, Protect, Translate: IP Strategies That Power the RNA Therapeutics Development Pipeline

This presentation will explore strategic approaches to intellectual property protection for RNA therapeutics, including miRNA, siRNA and other oligonucleotide-based innovations. Attendees will gain insights into building robust IP portfolios, from broad claims on target regions and platform technologies to precise, sequence-specific protections. The session will also address key patentability challenges, such as novelty, non-obviousness and adequate disclosure, while highlighting strategies to align IP development with scientific advancements. Designed for biotech innovators and decision-makers, this talk will provide actionable guidance to secure and translate RNA discoveries into impactful therapies.